Log in

News

Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

10 Dec 2020 9:23 PM | ISDE Office (Administrator)

Takashi Kojima , MD; Manish A. Shah , MD; Kei Muro, MD; Eric Francois; Antoine Adenis, MD, PhD; Chih-Hung Hsu, MD, PhD

Read the full abstract... 

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software